GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39527
Submission : 2024-02-08
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39527
Submission : 2024-02-08
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM; BUCCAL, SUBLINGUAL
Application Number : 205806
Country : US
Patented : No
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM; BUCCAL, SUBLINGUAL
Application Number : 205299
Country : US
Patented : No
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET; SUBLINGUAL
Application Number : 204431
Country : US
Patented : No
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Drug : PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE
Dosage Form : FOR SOLUTION; ORAL
Application Number : 204559
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : SUSPENSION; ORAL
Application Number : 74978
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : SOLUTION; ORAL
Application Number : 90461
Country : US
Patented : No
Drug : OXYCODONE HYDROCHLORIDE
Dosage Form : SOLUTION; ORAL
Application Number : 204085
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : SOLUTION; ORAL
Application Number : 90263
Country : US
Patented : No
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
Drug : CLENPIQ
Dosage Form : SOLUTION; ORAL
Application Number : 209589
Country : US
Patented : Yes
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
Drug : ADVIL ALLERGY AND CONGESTION RELIEF
Dosage Form : TABLET; ORAL
Application Number : 22113
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
25 Mar 2025
Reply
20 Sep 2024
Reply
15 Feb 2024
Reply
10 Jun 2023
Reply
30 Jan 2023
Reply
28 Feb 2022